Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial
Open accessThe DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is associated with visceral adiposity. We assessed the effectiveness of time-restricted fasting (TRF) for 16 h daily without calorie restrictions compared to standard care (SC; diet and lifestyle advice) in improving visceral adiposity and steatosis via controlled attenuation parameter (CAP). Methods: In a prospective single-blind randomized controlled trial, 32 participants with NAFLD were randomly assigned to TRF or SC for 12 weeks. The secondary endpoints were changes in liver stiffness, anthropometry, blood pressure, and other metabolic factors. Results: Twenty-eight participants completed the first arm of the study (TRF = 14, SC = 14), with 23 completing the crossover arm (TRF = 10, SC = 13). The baseline demographics were similar between the groups. Intermittent fasting caused a significant decrease in hepatic steatosis (p = 0.038), weight (p = 0.005), waist circumference (p = 0.001), and BMI (p = 0.005) compared to standard care. Intermittent fasting also resulted in additional within-group changes that were not seen in the standard care intervention. Conclusion: TRF offers superior improvements in patients with NAFLD, improving steatosis, weight, and waist circumference despite a lack of change in overall caloric intake. Time-restricted fasting should be considered as a primary weight loss intervention in the context of NAFLD. Trial registration: ACTRN12613000935730.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seven trials found no significant between-group differences in energy intake during the intervention (21, 24, 25), in change from baseline (16, 18, 25), or in post-intervention energy intake (20, 22), whereas two studies reported lower caloric intake in the IF groups than in the CER groups (23, 24).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Eight trials employed a parallel-group design (16, 18–24), and one utilized a crossover design (25).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Flint, A., Raben, A., Blundell, J., & Astrup, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801083 · Cited by 2,238
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,196
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.022 · Cited by 1,275 · cited 1×
“A subgroup of those with CAP values > 268 dB/m ( n = 10 [TRF], 10 [SC]), the cut-off considered for significant steatosis [18,19], demonstrated even larger decreases in CAP values after the TRF intervention, with a mean decrease of 26.10 ( ± 33.01) dB/m compared to an increase of 15.10 ( ± 17.49)…”
BackgroundInfluentialNon-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Yki-Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,259
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Self-citationAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852
Abdominal Fat: Standardized Technique for Measurement at CT
Yoshizumi, T., Nakamura, T., Yamane, M., Waliul Islam, A. H. M., Menju, M., Yamasaki, K., Arai, T., Kotani, K., Funahashi, T., Yamashita, S., et al. (1999) · Radiology · doi:10.1148/radiology.211.1.r99ap15283 · Cited by 829
Cited by
Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70132 · Cited by 153
Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 73
Tsitsou, S., Bali, T., Adamantou, M., Saridaki, A., Poulia, K., Karagiannakis, D. S., Papakonstantinou, E., & Cholongitas, Ε. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70044 · Cited by 45
Chrononutrition in the Prevention and Management of Metabolic Disorders: A Literature Review
Mentzelou, M., Papadopoulou, S. Κ., Psara, E., Voulgaridou, G., Pavlidou, E., Androutsos, O., & Giaginis, C. (2024) · Nutrients · doi:10.3390/nu16050722 · Cited by 48
The Catabolic—Anabolic Cycling Hormesis Model of Health and Resilience
Calabrese, E. J., & Mattson, M. P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102588 · Cited by 38
Paoli, A. (2025) · Nutrients · doi:10.3390/nu17040663 · Cited by 34
Rajewski, P., Cieściński, J., Rajewski, P., Suwała, S., Rajewska, A., & Potasz, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010217 · Cited by 39
Huang, L., Luo, Y., Zhang, L., Wu, M., & Hu, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03850-x · Cited by 19
Das, M., Kumar, D., Sauceda, C., Oberg, A., Ellies, L. G., Zeng, L., Jih, L., Newton, I. G., & Webster, N. J. G. (2024) · Cancers · doi:10.3390/cancers16081513 · Cited by 20
Khalafi, M., Rosenkranz, S. K., Ghasemi, F., Kheradmand, S., Maleki, A. H., Korivi, M., & Tsao, J.-P. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-024-00885-x · Cited by 17
Paredes-Marin, A., He, Y., & Zhang, X. (2025) · Nutrients · doi:10.3390/nu17213491 · Cited by 18
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Deng, Q., Lv, R., Zou, H., & Zou, T. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00368-x · Cited by 13
Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F. (2025) · Life · doi:10.3390/life15050696 · Cited by 9
“…improving visceral adiposity and steatosis compared with standard care and found a higher decrease in CAP values in the intermittent fasting group (n = 10) than in the standard care group (n = 13) and no significant difference in LSM values within and between the groups compared with baseline [37].”
Karjoo, S., Braglia‐Tarpey, A., Chan, A. P., Germán, A. G. A., Herdes, R. E., Pai, N., Velez, D. S., Whitehead, B. A., Quirós‐Tejeira, R. E., & Duro, D. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70099 · Cited by 9
Effects of induced molting on lipid accumulation in liver of aged laying hens
Lv, Y., Sun, M., He, Y., Zhang, X., Min, Y., Liu, L., & Yu, W. (2025) · Poultry Science · doi:10.1016/j.psj.2025.104941 · Cited by 10
Type 2 Diabetes Mellitus and Cardiometabolic Prospects: A Rapid Narrative Review
Chowdhury, K., Sinha, S., Ahmad, R., Lugova, H., Mehta, M., Kumar, S., & Haque, M. (2024) · Cureus · doi:10.7759/cureus.65808 · Cited by 7
Hamsho, M., Shkorfu, W., Terzi, M., Ranneh, Y., Varady, K. A., & Fadel, A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1887087 · Cited by 6
Current therapeutic landscape and future treatment perspectives of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10672-8 · Cited by 7
Zou, J., Tian, F., Cui, S., Hou, J. Y., Li, Z., Wei, Y., Cui, H., Li, Y., Zhou, S., He, Z., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04535-1 · Cited by 4
Park, J., Kim, M. S., & Boo, Y.-K. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf181 · Cited by 3
Nutritional and Fasting Strategies for the Management of MASLD / MASH : An Integrative Review
Tawk, D., Ghader, G., Khatib, Y., Attieh, P., Youssef, T., Othman, M., Harb, F., Azar, S. T., & Ghadieh, H. E. (2025) · JGH Open · doi:10.1002/jgh3.70315 · Cited by 4
Liu, Q., Zhang, L., Wang, Y., Li, J., & Li, Y. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102875 · Cited by 3
Haddad, R. R., Battula, N. S., Chay, T., Patel, T., Dumaru, N., Maddukuri, S., & Khan, S. (2025) · Cureus · doi:10.7759/cureus.84259 · Cited by 3
Classification and Health Implications of Different Intermittent Fasting Regimens
Kalam, F., Hafez, M., Ilori, T., Abdelrahim, D. N., & Akasheh, R. T. (2025) · Springer eBooks · doi:10.1007/978-981-96-6783-3_2 · Cited by 2
Yu, D., Yu, P., Huang, W., Zhang, P., & Li, L. (2025) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2025.11.006 · Cited by 3
Piana, K., Ziomber-Lisiak, A., & Szczerbowska‐Boruchowska, M. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.127428 · Cited by 2
Wu, H., Shi, Y., Wang, Z., Wei, Z., Chong, C., 熊化忠, Wang, Z., & Ren, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1701888 · Cited by 4
Li, H., & Li, T. (2026) · Frontiers in nutrition · doi:10.3389/fnut.2026.1833688 · Cited by 1
Astudillo-Guerrero, C., Fernandois, D., Caron, É., Prévot, V., Thaler, J. P., Dorfman, M. D., & Cruz, G. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00357.2025 · Cited by 1
Yang, L., Tie, X., Liu, X., Liu, Y., Li, F., Guo, Y., & Liang, Y. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01213-6 · Cited by 1
Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
Gugliucci, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14197026 · Cited by 1
Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Wang, R., Liu, Z., Lin, J., Zhang, W., Liu, X., & Zhang, T. (2026) · Portal hypertension & cirrhosis · doi:10.1002/poh2.70043 · Cited by 2
Sheng, L., Li, E., Ji, H., Cheng, S. C., Kwan, A., Bischof, E. Y., Chen, Y., & Pu, J. (2026) · npj Science of Food · doi:10.1038/s41538-026-00862-z · Cited by 1
Suilik, H. A., Gadelmawla, A. F., Rifai, M. K., Alhawi, M., Ashour, A., Abdalshafy, H., Bataineh, O. A., Rezq, H. S., Hani, A. B., Elkhattib, I., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103415 · Cited by 1
Sarmento‐Cabral, A., Novelle, M. G., Sánchez‐Mendoza, L. M., Hermán‐Sánchez, N., de la Haba, S. L., Rodriguez-Vazquez, M., Sanz, P., Chicano‐Gálvez, E., Cubero, F. J., Luque, R. M., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102432 · Cited by 1
Welche Arten von Forschung gibt es?
Kerckhoff, A., & Fesel, S. S. (2025) · Springer eBooks · doi:10.1007/978-3-662-71506-2_2
Su, J., Ma, G., Tang, X., Ma, Z., Xie, Z., & Peppelenbosch, M. P. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.102888
Alghzawi, A. O., Sawarkeh, S., Wafa, Q. A., Al-Azzeh, T., Aboudeh, R., & Mkhiemir, M. (2026) · Jordan Medical Journal · doi:10.35516/jmj.v60i1.3401
Valcin, J. A., Millender-Swain, T., Paul, J. R., Collins, B. K., Ghandour, F., Diffalha, S. A., Pollock, J. S., Pollock, D. M., Ballinger, S. W., Gamble, K. L., et al. (2026) · Function · doi:10.1152/function.082.2025
孙, 瑞. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162588
Metabolic effects of intermittent fasting (literature review)
Kuparadze, M., Imedashvili, G., Gegeshidze, N., Chaava, X., ZHORZHOLIANI, G., Morchiladze, M. M., & Silagadze, T. K. (2026) · Scientific Journal „Spectri“ · doi:10.52340/spectri.2025.12.02.05
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease with Lifestyle Modification
Ivancovsky-Wajcman, D., Pekas, E. J., de Avila, L., Gerber, L. H., & Zelber‐Sagi, S. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.01.002
Evidence Summary for Self-Management Education in Patients with Non-Alcoholic Fatty Liver Disease
Yang, Y., Cao, J., Zhang, L., Liu, J., & Li, M. T. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s590068
Oxymatrine: Hepatoprotective Effects of a Multitarget Natural Alkaloid
Zhang, Y., Ding, X., Zhou, M., Shi, J., Li, J., Zhu, Y., Ye, M., Wu, J., & Wang, W. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c00029
Jespersen, S., Fritt-Rasmussen, A., Durrer, C. G., Fallentin, E., Andersen, E. S., Thielsen, P., Bandholm, T., Madsbad, S., Pedersen, B. K., Ritz, C., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0351547
Jiang, W., Yang, Z., Cui, Y., Huang, N., Dong, L., Sun, T., & Zhang, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1902349
Tavakoli, A., Kermani, N., Zamani, P., Gargari, B. P., Dehghan, P., & Mirzaei, K. (2026) · Trials · doi:10.1186/s13063-026-09905-y
Sousa, C. S., Chaves, B. M. S., Moreira, A. L. S., Melo, S. Â. D., & de Oliveira, A. R. S. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i8.8726
Fadli, M., & Pamungkas, H. D. (2026) · California Medical Journal
(2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.65s.123
Duan, Z.-Q., Wang, H., Sun, C.-H., Wen, R., & Yu, H.-B. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.126681
Metadata
- Authors
- Feehan, J., Mack, A., Tuck, C., Tchongue, J., Holt, D. Q., Sievert, W., Moore, G. T., de Courten, B., & Hodge, A.
- Affiliations
- Victoria University (AU)
- Monash University (AU)
- Monash Health (AU)
- School of Health and Biomedical Sciences, RMIT, Bundoora 3083, Australia
- Corresponding author
- Hodge, Alexander
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-11-22
- Volume
- 15
- Issue
- 23
- Pages
- 4870
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10708421
- OpenAlex
- W4388906506
- Cited by
- 47
- References
- 41
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 5
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- Monash University
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, visceral fat, controlled attenuation parameter, liver stiffness, weight loss, waist circumference, intermittent fasting
- MeSH terms
- Intermittent Fasting, Humans, Liver, Prospective Studies, Single-Blind Method, Cross-Over Studies, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
